DURHAM, N.C.--(BUSINESS WIRE)--Patheon announced today the appointment of Gilles Cottier as president of the company’s pharmaceutical development services (PDS) division effective immediately. He will serve as a member of Patheon’s executive committee and will report to Patheon CEO James Mullen.
